GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (STU:4R0) » Definitions » Current Ratio

Oxford Nanopore Technologies (STU:4R0) Current Ratio : 4.45 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Oxford Nanopore Technologies's current ratio for the quarter that ended in Jun. 2024 was 4.45.

Oxford Nanopore Technologies has a current ratio of 4.45. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Oxford Nanopore Technologies's Current Ratio or its related term are showing as below:

STU:4R0' s Current Ratio Range Over the Past 10 Years
Min: 2.81   Med: 6.27   Max: 8.51
Current: 4.45

During the past 6 years, Oxford Nanopore Technologies's highest Current Ratio was 8.51. The lowest was 2.81. And the median was 6.27.

STU:4R0's Current Ratio is ranked better than
56.62% of 1503 companies
in the Biotechnology industry
Industry Median: 3.69 vs STU:4R0: 4.45

Oxford Nanopore Technologies Current Ratio Historical Data

The historical data trend for Oxford Nanopore Technologies's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Current Ratio Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Ratio
Get a 7-Day Free Trial 2.85 2.81 7.15 6.97 5.01

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 8.51 6.97 6.00 5.01 4.45

Competitive Comparison of Oxford Nanopore Technologies's Current Ratio

For the Biotechnology subindustry, Oxford Nanopore Technologies's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies's Current Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Current Ratio distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's Current Ratio falls into.



Oxford Nanopore Technologies Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Oxford Nanopore Technologies's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=519.072/103.539
=5.01

Oxford Nanopore Technologies's Current Ratio for the quarter that ended in Jun. 2024 is calculated as

Current Ratio (Q: Jun. 2024 )=Total Current Assets (Q: Jun. 2024 )/Total Current Liabilities (Q: Jun. 2024 )
=522.109/117.284
=4.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Nanopore Technologies  (STU:4R0) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Oxford Nanopore Technologies Current Ratio Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.

Oxford Nanopore Technologies Headlines

No Headlines